Molecular Partners Ag (MOLN) Operating Income (2022 - 2025)

Molecular Partners Ag (MOLN) has reported Operating Income for 4 consecutive years, with -$20.9 million the latest figure, recorded in Q2 2025.

• Quarterly Operating Income fell 18.4% year-over-year to -$20.9 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $102.1 million (changed N/A YoY) and the FY2025 annual result came in at -$72.7 million, down 4.07% from the prior year.
• Operating Income retreated to -$20.9 million in Q2 2025 per MOLN's latest filing, from -$17.7 million in the prior quarter.
• Over the last five years, Operating Income for MOLN reached as high as $158.4 million in Q2 2022 and fell as low as -$20.9 million in Q2 2025.
• A 4-year average of $25.5 million and a median of -$17.7 million in 2023 frame the typical range for Operating Income.
• Annual changes were most pronounced in 2023 — Operating Income tumbled 111.15% — and 2024, when it fell 0.01%.
• Year by year, Operating Income stood at $158.4 million in 2022, then slumped by 111.15% to -$17.7 million in 2023, then decreased by 0.01% to -$17.7 million in 2024, then dropped by 18.4% to -$20.9 million in 2025.
• According to Business Quant data, Operating Income over the past three periods registered -$20.9 million, -$17.7 million, and -$17.7 million for Q2 2025, Q2 2024, and Q2 2023 respectively.